RNAC insider buying and SEC filings, explained
Cartesian Therapeutics, Inc. · CIK 1453687
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$206K
Insiders who bought
1
Sold (not marked 10b5-1)
$259K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jan 6, 2026 | Sale | Carsten Brunn (CEO and Director) sold 23,766 shares at $6.82 ($162K). Holdings down 7% to 323,530 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
| Jan 6, 2026 | Sale | Milos Miljkovic (Chief Medical Officer) sold 3,573 shares at $6.82 ($24K). Holdings down 6% to 58,820 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
| Jan 6, 2026 | Sale | Blaine Davis (CFO) sold 10,591 shares at $6.82 ($72K). Holdings down 8% to 121,220 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
| Dec 4, 2025 | Purchase (code P) | Timothy C. Barabe (Director) bought 30,000 shares at about $6.86 ($206K), reported as a purchase (code P). Holdings up 123% to 54,366 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 8, 2025 |
19 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RNAC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.